← Back
Data updated: Mar 10, 2026
VALEANT PHARMS NORTH
DermatologyCardiovascular
VALEANT PHARMS NORTH is a pharmaceutical company focused on Dermatology, Cardiovascular.
1973
Since
9
Drugs
-
Trials
49
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-18
Labeling
DILTIAZEM HYDROCHLORIDE 2025-11-14
VENLAFAXINE HYDROCHLORIDE 2025-09-17
Labeling
DILTIAZEM HYDROCHLORIDE 2025-09-11
Labeling
DILTIAZEM HYDROCHLORIDE 2025-09-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 50%
1 drugs
Cardiovascular 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (4)
Discontinued (5)
Company Info
- First Approval
- 1973-01-26
- Latest
- 2025-07-11
- Applications
- 12